Medicare’s $50 Per Month GLP-1 Bridge: What You Need to Know | Sheppard
In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic and…
Blog
In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic and…
As GLP-1 medications become an increasingly significant cost driver for employer-sponsored health plans, plan sponsors are seeking creative solutions beyond…
More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical…